Natural killer cells: a promising immunotherapy for cancer
J Chu, F Gao, M Yan, S Zhao, Z Yan, B Shi… - Journal of translational …, 2022 - Springer
As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …
recently gained attention as an important type of innate immune regulatory cell. NK cells can …
Current landscape of therapeutic resistance in lung cancer and promising strategies to overcome resistance
Simple Summary Despite an initial response to therapy, many lung cancer patients
inevitably develop resistance to therapy leading to decreased duration of response and …
inevitably develop resistance to therapy leading to decreased duration of response and …
The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
The complex orchestration of gene expression that mediates the transition of epithelial cells
into mesenchymal cells is implicated in cancer development and metastasis. As the primary …
into mesenchymal cells is implicated in cancer development and metastasis. As the primary …
[HTML][HTML] Mechanisms of action and clinical implications of MicroRNAs in the drug resistance of gastric cancer
Y Liu, X Ao, G Ji, Y Zhang, W Yu, J Wang - Frontiers in oncology, 2021 - frontiersin.org
Gastric cancer (GC) is one of the most common malignant tumors of digestive systems
worldwide, with high recurrence and mortality. Chemotherapy is still the standard treatment …
worldwide, with high recurrence and mortality. Chemotherapy is still the standard treatment …
Current opinion on the pharmacogenomics of paclitaxel-induced toxicity
ZN Al-Mahayri, MM AlAhmad, BR Ali - Expert Opinion on Drug …, 2021 - Taylor & Francis
Introduction: Paclitaxel is a microtubule stabilizer that is currently one of the most utilized
chemotherapeutic agents. Its efficacy in breast, uterine, lung and other neoplasms made its …
chemotherapeutic agents. Its efficacy in breast, uterine, lung and other neoplasms made its …
[HTML][HTML] MicroRNAs as predictors of lung-cancer resistance and sensitivity to cisplatin
M Konoshenko, Y Lansukhay, S Krasilnikov… - International journal of …, 2022 - mdpi.com
Background: Platinum-based chemotherapy, cisplatin (DDP) specifically, is the main
strategy for treating lung cancer (LC). However, currently, there is a lack of predictive drug …
strategy for treating lung cancer (LC). However, currently, there is a lack of predictive drug …
An antioxidant feedforward cycle coordinated by linker histone variant H1. 2 and NRF2 that drives nonsmall cell lung cancer progression
Y Chen, J Shi, X Wang, L Zhou… - Proceedings of the …, 2023 - National Acad Sciences
Nonsmall cell lung cancer (NSCLC) is highly malignant with limited treatment options,
platinum-based chemotherapy is a standard treatment for NSCLC with resistance commonly …
platinum-based chemotherapy is a standard treatment for NSCLC with resistance commonly …
Kaempferol sensitizes cell proliferation inhibition in oxaliplatin-resistant colon cancer cells
J Park, GE Lee, HJ An, CJ Lee, ES Cho… - Archives of Pharmacal …, 2021 - Springer
Resolution to chemoresistance is a major challenge in patients with advanced-stage
malignancies. Thus, identification of action points and elucidation of molecular mechanisms …
malignancies. Thus, identification of action points and elucidation of molecular mechanisms …
Nanomedicine-based adjuvant therapy: a promising solution for lung cancer
Lung cancer has been the leading cause of cancer-related deaths worldwide for decades.
Despite the increasing understanding of the underlying disease mechanisms, the prognosis …
Despite the increasing understanding of the underlying disease mechanisms, the prognosis …
Cancer bioenergetics and tumor microenvironments—Enhancing chemotherapeutics and targeting resistant niches through nanosystems
Simple Summary Cancer remains a major killer of the human population. Current cancer
diagnostic and therapeutic methods are associated with shortcomings of limited targetability …
diagnostic and therapeutic methods are associated with shortcomings of limited targetability …